Tag: Databricks

Browse our exclusive articles!

Databricks Raises $500M, Valuation Soars to $43B as AI Focus Drives Growth, US

Databricks raises $500M in funding to propel its AI-focused software, reaching a valuation of $43B. Strategic partnerships and growth plans in place.

Databricks in Talks for Fresh Funding Round, Valuation Could Surpass $43B, US

Databricks, the big data software giant, is in talks with T. Rowe Price for additional funding that could push its valuation beyond $43 billion. Discover how Databricks revolutionizes big data analytics with its efficient software and robust security options.

Microsoft Brings AI Competition to OpenAI with Databricks Deal

Microsoft partners with Databricks to offer new AI software through Azure, challenging OpenAI's licensing model. Explore the promising future of AI development.

Databricks Seeks Massive Cash Infusion to Capitalize on AI Frenzy

Databricks seeks significant cash infusion to fuel growth in AI-driven enterprise software. Investors recognize its potential in revolutionizing industries.

AtScale Expands Microsoft Analytics Integration to Empower Power BI and Excel Users

AtScale announces expanded integrations with Microsoft Power BI and Excel, empowering data teams with enhanced analytics capabilities.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img